Dual blockade with AFatinib and trastuzumab as NEoadjuvant treatment for patients with locally advanced or operable breast cancer receiving taxane-anthracycline containing chemotherapy-DAFNE (GBG-70) - Hanusch, Claus Alexander; Schneeweiss, Andreas; Loibl, Sibylle; Untch, Michael; Paepke, Stefan; Kümmel, Sherko; Jackisch, Christian; Huober, Jens; Hilfrich, Jörn; Gerber, Bernd; Eidtmann, Holger; Denkert, Carsten; et al. (Clinical cancer research, 2015)